Plan to meet the IPA team at our booth (#622) to find out how to accelerate therapeutic antibody discovery utilizing advanced, innovative technologies yielding greater candidate diversity than traditional methods. Or, schedule a meeting to discuss a custom antibody discovery plan for your next project.
At hubXchange’s European Antibody Therapeutics event, held in Munich on March 21st, Dr. Debby Kruijsen will lead a round-table discussion entitled “Implementing discovery strategies to value the therapeutic potential of lead antibody candidates” while Nienke Smits will present a poster entitled “DeepDisplay™: a powerful and unique human lead antibody discovery platform utilizing OmniMouse®”.
While attending this event, the ImmunoPrecise team will also be participating in one-on-one meetings with current and potential clients.
Attending from ImmunoPrecise will be Dr. Jennifer Bath and Kari Graber. Stop by booth #11 to learn more about how we may help with your antibody discovery and protein engineering needs to accelerate your therapeutic pipeline.
ImmunoPrecise will be attending PepTalk 2019, the Protein Science Week, from January 14-18th, 2019. PepTalk is the largest annual gathering of protein science researchers in the world. The conference focuses on intensive learning to discover new opportunities, apply alternative solutions and develop promising partnerships through keynote speakers, seminars and short courses.
Meet Us at Booth 700
Attending from ImmunoPrecise will be Dr. Deanna Dryhurst and Fiona Zhang-Ruane. Schedule a meeting and stop by booth #700 to learn more about how we may help with your antibody discovery and protein engineering needs to accelerate your therapeutic pipeline.
Meet with our global team at Booth #107 to find out more about our comprehensive collection of antibody discovery platforms and how we can accelerate next generation antibodies to commercial success. This event features plenty of opportunities for networking and collaborating with leading pharma, biotech, and academia from North America, Asia, and Europe.
Schedule a Meeting with us to learn about how we can further your therapeutic antibody discovery.
ImmunoPrecise’s CEO and President, Dr. Jennifer Bath spoke with SNNLive at the SmallCap Discoveries Conference 2018 in Vancouver.
Check Out the Video to Find out More On:
The overview and history of ImmunoPrecise Antibodies, what makes IPA unique in the marketplace, target customer base, the challenges pharmaceutical companies face when going through the process of outsourcing their pharmaceutical drug discovery, Dr. Bath’s background, and growth drivers.
StockNewsNow.com is a microcap financial news portal that features news and insights from the microcap and emerging growth financial community. StockNewsNow.com is a multimedia destination hub for information about microcap and emerging growth public and private companies, market events, news, bulletins, stock quotes, expert commentary and company profiles that feature SNN-produced video like SNNLive CEO video interviews, as well as their latest news and headlines. Users can engage directly and share the information provided through social media.